Dyslipidemia Flashcards
Composition
HDL = Good
Cholesterol and Triglycerides = Bad
Atherosclerosis
Inflammation in arterial wall
LABS
Know ideals, not risks. Total cholesteral < 100 HDL >60 Trigliceriedes <150 Serum Cholesterol <200
Managing Dyslipidemia
- Lifestyle
- HMG-CoA reductase inhibitor is a STATIN (lower LDL by 20-40% and measure at 4 weeks)
- Bile-acid sequestrants (often combined with statins)…inc. excretion of LDL (cholesterol) in stool
- Nicotinic Acid (often used with Bile-Acid Sequestrants)…dec.VLDL and dec. LDL levels, inc. vasodilation of capillaries.
- Fibrates (second line therapy)…dec. triglyceride levels and inc. HDL (DO NOT lower LDLs)
- Ezitimibe (cholesterol absorption inhibitor)…stops absorption of cholesterol in food & MUST be taken with statin.
Why are statins great?
trifecta: lower LDL by 25-60%, raise HDL by 6-12%, lower TG by 14-29%.
HMG CoA Reductase Inhibitor
Statin Prototype: atorvastatin (Lipitor) Check cholesterol after 4 weeks -Freq. monitoring of LFTs, AST, ALT -Baseline Liver Function test
Atorvastatin
Routes: PO
Onset: 2-4 weeks
Duration of Action: Half life 14 hrs/30 hr active metabolites
Indications: Hypercholesterolemia and CV event prevention.
Mechanisms of Action:
Adverse effects: GI, diarrhea/constipation, rhabdomyolysis (breakdown of muscle fibers), liver failure (S/sx of muscle cramps/weakness/pain/myopathy/myalgia)
Contraindications: prego, lactation, liver impairment
Bile Acid Sequestrants
Questran
Questran
Route: PO
Onset: 1-2 days, 30 days for max effect.
Duration: 2-4 weeks
Indications: Hypercholesterolemia, pruritis assoc. with biliary obstruction. (don’t need to know)
Mechanisms: Binds to bile acids, lowers LDL
Adverse Effects: GI, constipation, bloating, belching, nausea, GI tract obstruction, hyperchloremic acidosis, *malabsorption syndrome.
ContraIndications: Complete biliary obstruction, caution in GI disorders
Prego: Category B, possible interference with vitamin absorption.
S/Sx light and urine dark, pain and vomiting.
Niacin (Niaspan)
Route: PO
Onset: 30-60min.
Duration of action: 5 hr
Indications: dyslipidemia
Mechanisms: Dec. production of VLDL, incl. HDL, B-complex vitamin.
Adverse effects: facial flushing/hot flashes, GI/nausea/excess gas/diarrhea/hepatotoxicity/gout.
Contraindications: none. **Caution in diabetes and hx of liver disease. dec. insulin.
Prego: Category C
Gemfibrozil (Lopid)
Route: PO
Onset: 1-2 hrs
Duration: Half life 1.5 hrs.
Indications: Hypertriglyceridemia, 2nd line therapy after statins
Mechanisms: Thought to inhibit lipolysis in adipose tissue, inc. excretion of TG in feces.
Adverse Effects: GI abdominal cramping, diarrhea, nausea, dyspepsia (indigestion), diminished libido, cholelithiasis (gall stones), anemia, rhabdomyolysis with statins.
Contraindications: CAUTION in gallbladder, liver, and kidney disease.
Prego Category C
Cholesterol Absorption Inhibitor
Prototype = ezetimibe
-Blocks absorption of cholesterol in the small intestine and MUST be administered with statin b/c body responds by making more cholesterol.
-Now a 2nd or 3rd line agent.
-Adverse effect: Nasopharyngitis, myalgia, arthralgias, URI, diarrhea, **GI/Muscle
Category C.
Combination Drugs
Niacin/Lovastatin Simvastatin/Niacin Simvastatin/Ezetimibe Pravastatin/Aspirin Atorvastatin/Amlodipine